These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
278 related items for PubMed ID: 17689481
1. Hormonal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Bachelot A, Chakhtoura Z, Rouxel A, Dulon J, Touraine P. Ann Endocrinol (Paris); 2007 Sep; 68(4):274-80. PubMed ID: 17689481 [Abstract] [Full Text] [Related]
2. Classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults. Bachelot A, Chakthoura Z, Rouxel A, Dulon J, Touraine P. Horm Res; 2008 Sep; 69(4):203-11. PubMed ID: 18204267 [Abstract] [Full Text] [Related]
3. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency--management in adults]. Ambroziak U, Bednarczuk T, Ginalska-Malinowska M, Małunowicz EM, Grzechocińska B, Kamiński P, Bablok L, Przedlacki J, Bar-Andziak E. Endokrynol Pol; 2010 Sep; 61 Suppl 1():7-21. PubMed ID: 22127631 [Abstract] [Full Text] [Related]
4. Long-term outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Bachelot A, Plu-Bureau G, Thibaud E, Laborde K, Pinto G, Samara D, Nihoul-Fékété C, Kuttenn F, Polak M, Touraine P. Horm Res; 2007 Sep; 67(6):268-76. PubMed ID: 17170529 [Abstract] [Full Text] [Related]
6. Congenital adrenal hyperplasia in adults: a review of medical, surgical and psychological issues. Ogilvie CM, Crouch NS, Rumsby G, Creighton SM, Liao LM, Conway GS. Clin Endocrinol (Oxf); 2006 Jan; 64(1):2-11. PubMed ID: 16402922 [Abstract] [Full Text] [Related]
7. Congenital adrenal hyperplasia--pharmacologic interventions from the prenatal phase to adulthood. Claahsen-van der Grinten HL, Stikkelbroeck NM, Otten BJ, Hermus AR. Pharmacol Ther; 2011 Oct; 132(1):1-14. PubMed ID: 21635919 [Abstract] [Full Text] [Related]
8. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency - management in adults. Ambroziak U, Bednarczuk T, Ginalska-Malinowska M, Małunowicz EM, Grzechocińska B, Kamiński P, Bablok L, Przedlacki J, Bar-Andziak E. Endokrynol Pol; 2010 Oct; 61(1):142-55. PubMed ID: 20205117 [Abstract] [Full Text] [Related]
9. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross-sectional study of factors involved in bone mineral density. de Almeida Freire PO, de Lemos-Marini SH, Maciel-Guerra AT, Morcillo AM, Matias Baptista MT, de Mello MP, Guerra G. J Bone Miner Metab; 2003 Oct; 21(6):396-401. PubMed ID: 14586796 [Abstract] [Full Text] [Related]
10. Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency. Chakhtoura Z, Bachelot A, Samara-Boustani D, Ruiz JC, Donadille B, Dulon J, Christin-Maître S, Bouvattier C, Raux-Demay MC, Bouchard P, Carel JC, Leger J, Kuttenn F, Polak M, Touraine P, Centre des Maladies Endocriniennes Rares de la Croissance and Association Surrénales. Eur J Endocrinol; 2008 Jun; 158(6):879-87. PubMed ID: 18390993 [Abstract] [Full Text] [Related]
12. Puberty and fertility in congenital adrenal hyperplasia. Otten BJ, Stikkelbroeck MML, Claahsen-van der Grinten HL, Hermus ARMM. Endocr Dev; 2005 Jun; 8():54-66. PubMed ID: 15722617 [Abstract] [Full Text] [Related]
13. Success of glucocorticoid replacement therapy on fertility in two adult males with 21-CAH homozygote classic form. Valentino R, Savastano S, Tommaselli AP, Scarpitta MT, Dorato M, Gigante M, Calvanese E, Carlino M, Lombardi G. J Endocrinol Invest; 1997 Dec; 20(11):690-4. PubMed ID: 9492111 [Abstract] [Full Text] [Related]
15. Health problems in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Reisch N, Arlt W, Krone N. Horm Res Paediatr; 2011 Dec; 76(2):73-85. PubMed ID: 21597280 [Abstract] [Full Text] [Related]